Wei-Ann Hsueh, MD
Anesthesiology · New York, NYNPI 1255652806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 28.6% of the total. 2025 is the largest year on record at $484, more than ten times the $18 reported in 2020.
Across 38 payments — averaging $24.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$267
- Lilly USA, LLC$158
- Ardelyx, Inc.$93
- Johnson & Johnson$85
- AbbVie$79
- Celltrion USA Inc.$65
- plus $186 from 8 others
What the payments were for
- Food & beverage$934100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $267 |
| Lilly USA, LLC | 5 | $158 |
| Ardelyx, Inc. | 4 | $93 |
| Johnson & Johnson | 2 | $85 |
| AbbVie | 3 | $79 |
| Celltrion USA Inc. | 3 | $65 |
| Boehringer Ingelheim | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Merck | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi | 1 | $18 |
How this compares
$934 in reported general payments places this provider in the 85th percentile of 4,157 anesthesiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in New York
- Kiran PatelNew York$832K
- Marc DicksteinNew York$585K
- Admir HadzicNew York$510K
- Christopher DimeoNew York$449K
- Christopher RieglerNew York$429K
- William UrmeyNew York$397K
- Sudhir DiwanNew York$255K
- Daniel KatzNew York$190K
- Anoushka AfonsoNew York$59K
- Alex BekkerNew York$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.